akhilobbilisetty retweetledi
I am Dr. Sivaranjani, a pediatrician , raising concerns about how ERZL is being marketed and positioned in pharmacies, and the risk it creates for consumers making critical decisions during dehydration.
This issue is not about whether ERZL is safe in isolation.
It is about how it is presented, perceived, and potentially misunderstood in real-world settings.
ERZL is a commercially marketed electrolyte drink. However, its branding and advertising raise serious concerns.
*It should not be using ORSL in its communication.*
Why?
Because:
* ORSL itself is not the original medically recommended ORS
* Referencing ORSL in any form creates brand recall in the minds of consumers
* Instead of reducing confusion, it continues and reinforces it
When ERZL is positioned as a continuation or replacement of ORSL, it keeps that same association alive — especially among parents who may already believe ORSL was equivalent to ORS.
👉 This defeats the very purpose of regulatory action.
In pharmacy settings:
* People are often making quick decisions under stress
* They rely on familiar names and visual cues
* Branding can directly influence what they choose
If ERZL continues to build on ORSL recall, it risks being perceived as a medical solution for dehydration, even when it is not the same as ORS (the medically recommended solution).
There are also concerns around ingredients like sucralose, especially in children and with prolonged use, based on global health guidance.
This makes clear communication even more important.
After raising these concerns, I have received a legal notice from Johnson & Johnson and Kenvue.
This petition is not about conflict.
It is about:
* Clarity in healthcare communication
* Preventing consumer confusion
* Ensuring responsible branding and advertising
* Allowing doctors to raise public health concerns without hesitation
We urge the Food Safety and Standards Authority of India and the Ministry of Health and Family Welfare to:
1 *. Ensure that, since ERZL closely resembles ORSL, Kenvue is directed to rebrand it in a way that does not create recall or association with ORSL.*
2. Prevent misleading positioning that may confuse consumers
3. Strengthen enforcement at the pharmacy level
4. Ensure clear differentiation from medically recommended ORS
5. Protect healthcare professionals raising genuine concerns
In healthcare, even small confusion can have big consequences. Clear choices save lives.
@fssai @JPNadda
@MoHFW_INDIA @narendramodi
Stand for public health. Sign and share this petition to help protect every family from confusion in critical moments.
c.org/4wzT58q4wN
English
